Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

J. Rusthoven, James; A. Eisenhauer, Elizabeth; Butts, Charles; Gregg, Richard; Dancey, Janet; Fisher, B.; Iglesias, José

doi:10.1200/jco.1999.17.4.1194

Public

Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

Published in Journal of Clinical Oncology • Apr 1, 1999

Authors:

James J. Rusthoven

Elizabeth A. Eisenhauer

Charles Butts

Abstract

PURPOSE: To evaluate the efficacy and safety of the multitargeted antifolate LY231514 (MTA) in patients receiving initial chemotherapy for unresectable, advanced non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: Patients with measurable, advanced NSCLC who had not received previous chemother...

Subject

Medicine

Chemotherapy

Lung cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!